​
​

Metacrine Ownership | Who Owns Metacrine?

OverviewChart

Metacrine Ownership Summary

Metacrine is owned by 21.82% institutional investors, and 78.18% retail investors.

MTCR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMetacrine21.82%-78.18%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20235-81.48%9,289,426-42.93%211.49%1-90.91%1-85.71%
Dec 31, 20222722.73%16,276,932100.84%3810.55%1122.22%775.00%
Sep 30, 202222-8,104,59632.39%199.15%928.57%4-42.86%
Jun 30, 202222-26.67%6,121,772-2.61%146.48%7-65.00%775.00%
Mar 31, 202230-3.23%6,285,61190.35%1424.26%2017.65%4-33.33%

Recent Insider Transactions

DateNameRoleActivityValue
Jan 26, 2023York Michael Chief Business OfficerSell$44.33K
Jan 26, 2023Klassen Preston President & CEOSell$157.27K
Dec 20, 2022Leonard Braden Michael-Buy$19.00K
Dec 19, 2022Leonard Braden Michael-Buy$40.55K
Dec 21, 2022Leonard Braden Michael-Buy$48.04K

Insider Transactions Trends

DateBuySell
2023 Q1-2
2022 Q411-
2022 Q2-1
2022 Q1--
2021 Q4-29

MTCR Ownership FAQ

Who Owns Metacrine?

Metacrine shareholders are primarily institutional investors at 21.82%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Metacrine's industry, Biotech Stocks , is 44.97%, which Metacrine falls below.

Does Blackrock own Metacrine?

BlackRock is not among the top 10 institutional shareholders of Metacrine.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools